Integrating TNFAIP6 expression data with clinical parameters, such as age, estimated glomerular filtration rate (eGFR), inflammatory markers, and dialysis adequacy, may improve diagnostic accuracy and support individualized treatment strategies in HD-managed CKD [44]. The gene discussed is TNFAIP6; the disease is chronic kidney disease.